Your browser doesn't support javascript.
loading
Leukocyte telomere length in patients with myotonic dystrophy type I: a pilot study.
Wang, Youjin; Best, Ana; Fernández-Torrón, Roberto; Alsaggaf, Rotana; Garcia-Puga, Mikel; Dagnall, Casey L; Hicks, Belynda; Thompson, Mone't; Matheu Fernandez, Ander; Zulaica Ijurco, Miren; Greene, Mark H; Lopez de Munain, Adolfo; Gadalla, Shahinaz M.
Afiliação
  • Wang Y; Clinical Genetics Branch, Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, Bethesda, Maryland.
  • Best A; Biostatistics Branch, Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, Bethesda, Maryland.
  • Fernández-Torrón R; Centro de Investigación Biomédica en Red sobre Enfermedades Neurodegenerativas, Institute Carlos III, Madrid, Spain.
  • Alsaggaf R; Neuroscience Area, Institute Biodonostia, San Sebastian, Spain.
  • Garcia-Puga M; Clinical Genetics Branch, Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, Bethesda, Maryland.
  • Dagnall CL; Neuroscience Area, Institute Biodonostia, San Sebastian, Spain.
  • Hicks B; Cancer Genomics Research Laboratory, Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, Bethesda, Maryland.
  • Thompson M; Cancer Genomics Research Laboratory, Leidos Biomedical Research, Inc., Frederick National Laboratory for Cancer Research, Frederick, Maryland.
  • Matheu Fernandez A; Cancer Genomics Research Laboratory, Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, Bethesda, Maryland.
  • Zulaica Ijurco M; Cancer Genomics Research Laboratory, Leidos Biomedical Research, Inc., Frederick National Laboratory for Cancer Research, Frederick, Maryland.
  • Greene MH; Clinical Genetics Branch, Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, Bethesda, Maryland.
  • Lopez de Munain A; Oncology Area, Biodonostia Health Research Institute, San Sebastián, Spain.
  • Gadalla SM; Centro de Investigación Biomédica en Red sobre Enfermedades Neurodegenerativas, Institute Carlos III, Madrid, Spain.
Ann Clin Transl Neurol ; 7(1): 126-131, 2020 01.
Article em En | MEDLINE | ID: mdl-31808320
ABSTRACT
Myotonic dystrophy type I (DM1) is an autosomal dominant disease of which clinical manifestations resemble premature aging. We evaluated the contribution of telomere length in pathogenesis in 361 DM1 patients (12 with serial measurements) and 223 unaffected relative controls using qPCR assay. While no differences in baseline leukocyte relative telomere length (RTL) was noted, the data suggested an accelerated RTL attrition in DM1 (discovery cohort T/S change/year = -0.013 in DM1 vs. -0.005 in controls, P = 0.04); similar trend was noted in validation cohort. Further investigations are needed to examine the role of TL in the pathophysiology of DM1.
Assuntos

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Encurtamento do Telômero / Leucócitos / Distrofia Miotônica Limite: Adult / Female / Humans / Male / Middle aged Idioma: En Ano de publicação: 2020 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Encurtamento do Telômero / Leucócitos / Distrofia Miotônica Limite: Adult / Female / Humans / Male / Middle aged Idioma: En Ano de publicação: 2020 Tipo de documento: Article